These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16215273)

  • 1. Proteomic analysis of lysosomal acid hydrolases secreted by osteoclasts: implications for lytic enzyme transport and bone metabolism.
    Czupalla C; Mansukoski H; Riedl T; Thiel D; Krause E; Hoflack B
    Mol Cell Proteomics; 2006 Jan; 5(1):134-43. PubMed ID: 16215273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocytes/Macrophages Upregulate the Hyaluronidase HYAL1 and Adapt Its Subcellular Trafficking to Promote Extracellular Residency upon Differentiation into Osteoclasts.
    Puissant E; Boonen M
    PLoS One; 2016; 11(10):e0165004. PubMed ID: 27755597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
    J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
    Merle B; Itzstein C; Delmas PD; Chenu C
    J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
    Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS
    J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic identification of the TRAF6 regulation of vacuolar ATPase for osteoclast function.
    Ryu J; Kim H; Lee SK; Chang EJ; Kim HJ; Kim HH
    Proteomics; 2005 Nov; 5(16):4152-60. PubMed ID: 16196101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-4 inhibits bone-resorbing activity of mature osteoclasts by affecting NF-kappa B and Ca2+ signaling.
    Mangashetti LS; Khapli SM; Wani MR
    J Immunol; 2005 Jul; 175(2):917-25. PubMed ID: 16002690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones.
    Swanson C; Lorentzon M; Conaway HH; Lerner UH
    Endocrinology; 2006 Jul; 147(7):3613-22. PubMed ID: 16614077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis.
    Kim Y; Sato K; Asagiri M; Morita I; Soma K; Takayanagi H
    J Biol Chem; 2005 Sep; 280(38):32905-13. PubMed ID: 16046394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polarized secretion of lysosomal enzymes: co-distribution of cation-independent mannose-6-phosphate receptors and lysosomal enzymes along the osteoclast exocytic pathway.
    Baron R; Neff L; Brown W; Courtoy PJ; Louvard D; Farquhar MG
    J Cell Biol; 1988 Jun; 106(6):1863-72. PubMed ID: 2968345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption.
    Xing L; Carlson L; Story B; Tai Z; Keng P; Siebenlist U; Boyce BF
    J Bone Miner Res; 2003 Feb; 18(2):260-9. PubMed ID: 12568403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand.
    Xu J; Tan JW; Huang L; Gao XH; Laird R; Liu D; Wysocki S; Zheng MH
    J Bone Miner Res; 2000 Nov; 15(11):2178-86. PubMed ID: 11092398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor.
    Kaneda T; Nojima T; Nakagawa M; Ogasawara A; Kaneko H; Sato T; Mano H; Kumegawa M; Hakeda Y
    J Immunol; 2000 Oct; 165(8):4254-63. PubMed ID: 11035059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo.
    Chiusaroli R; Knobler H; Luxenburg C; Sanjay A; Granot-Attas S; Tiran Z; Miyazaki T; Harmelin A; Baron R; Elson A
    Mol Biol Cell; 2004 Jan; 15(1):234-44. PubMed ID: 14528021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption.
    Zheng H; Yu X; Collin-Osdoby P; Osdoby P
    J Biol Chem; 2006 Jun; 281(23):15809-20. PubMed ID: 16613848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.
    Burgess TL; Qian Y; Kaufman S; Ring BD; Van G; Capparelli C; Kelley M; Hsu H; Boyle WJ; Dunstan CR; Hu S; Lacey DL
    J Cell Biol; 1999 May; 145(3):527-38. PubMed ID: 10225954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human osteoclast culture from peripheral blood monocytes: phenotypic characterization and quantitation of resorption.
    Buckley KA; Chan BY; Fraser WD; Gallagher JA
    Methods Mol Med; 2005; 107():55-68. PubMed ID: 15492364
    [No Abstract]   [Full Text] [Related]  

  • 20. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.
    Li J; Sarosi I; Yan XQ; Morony S; Capparelli C; Tan HL; McCabe S; Elliott R; Scully S; Van G; Kaufman S; Juan SC; Sun Y; Tarpley J; Martin L; Christensen K; McCabe J; Kostenuik P; Hsu H; Fletcher F; Dunstan CR; Lacey DL; Boyle WJ
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1566-71. PubMed ID: 10677500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.